Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

NEPTUNE I and II data on tamsulosin/solifenacin presented

Oct. 22, 2012

Phase II and III studies of bardoxolone methyl suspended

Oct. 19, 2012

Researchers describe activity of TAC-302

Oct. 19, 2012

Mitsubishi Tanabe and Kureha complete EPPIC phase III studies

Oct. 10, 2012

Encouraging follow-up data emerges from phase IIb PRX-302 study

Oct. 10, 2012

AstraZeneca and Ardelyx sign licensing deal for NHE-3 inhibitor program

Oct. 10, 2012

Mirabegron safe in male patients with bladder outlet obstruction

Oct. 8, 2012

Bayer Yakuhin seeks additional approval for Fosrenol chewable tablets and granules in Japan

Oct. 5, 2012

Votubia recommended for approval in Europe

Sep. 26, 2012

CHMP gives positive opinion on Cialis in new indication

Sep. 26, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...